位置：成果数据库 > 期刊 > 期刊详情页
炎症机制可能参与心脏X综合征的发生与发展
  • 期刊名称：中国心血管病研究杂志
  • 时间：0
  • 页码：801-803
  • 语言：中文
  • 分类：R605.973[医药卫生—急诊医学;医药卫生—临床医学;医药卫生—外科学] R541[医药卫生—心血管疾病;医药卫生—临床医学;医药卫生—内科学]
  • 作者机构：[1]中国医学科学院暨中国协和医科大学阜外心血管病研究所暨阜外心血管病医院冠心病诊疗中心,北京市100037
  • 相关基金：阜外医院人才启动基金（2004190）;国家自然科学基金（30670861,30871055）;北京市自然科学基金（7082081）;中国高等教育博士点项目专项研究基金（20060023044,20070023047）
  • 相关项目：冠脉慢血流综合征的炎症相关分子机制研究与他汀干预
作者： 李建军|
关键词： 炎症机制, 心脏X综合征, 动脉粥样硬化, 临床表现, 生物学反应, 冠心病
中文摘要：

长期以来，人们已经认识到，炎症是机体对损伤的一种基本的生物学反应。然而，新近的研究发现，炎症同时也是动脉粥样硬化的病因，炎症参与了动脉粥样硬化发生与发展的所有阶段并与冠心病的不同临床状态与临床表现形式有关。

同期刊论文项目
冠脉慢血流综合征的炎症相关分子机制研究与他汀干预
期刊论文 34
冠状动脉慢血流现象发生的炎症机制研究
期刊论文 23
同项目期刊论文
Gender difference of clinical characteristics in Chinese patients with spontaneous variant angina
炎症与动脉粥样硬化的新视野
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of
Chronic inflammatory status in patients with coronary artery ectasia
Comparison of Changes in Early Inflammatory Markers Between Sirolimus- and Paclitaxel-Eluting Stent
无痛性心肌缺血与炎症
冠状动脉慢血流综合征与炎症的关系
C反应蛋白:动脉粥样硬化的标志物还是兼具致病作用
炎症可能是支架内再狭窄发生的重要机制
内皮祖细胞、动脉硬化与炎症
Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth M
Is myocardial bridging a bridge connecting to cardiovascular events?
Impact of C-Reactive Protein on In-Stent Restenosis A Meta-Analysis
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data
Anatomic properties of coronary arteries are correlated to corrected TIMI frame count in coronary sl
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhib
A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery
Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic l
冠状动脉慢血流现象应视为一种新的冠状动脉综合征
再狭窄发生的相关研究是冠心病介入治疗的长期课题
支架内再狭窄与炎症相关吗?
Inflammation in coronary artery diseases
冠状动脉慢血流现象的发生机制和临床诊治进展
他汀类药物非调脂作用及其机制（续完）
内皮祖兰田胞、动脉硬化与炎症
炎症与支架内再狭窄
炎症可能是联接高血压和动脉粥样硬化的桥梁
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway
Gender difference of clinical characteristics in Chinese patients with spontaneous variant angina
冠状动脉慢血流综合征与炎症的关系
炎症可能是支架内再狭窄发生的重要机制
Is myocardial bridging a bridge connecting to cardiovascular events?
再狭窄发生的相关研究是冠心病介入治疗的长期课题
Inflammation in coronary artery diseases
Statin may be beneficial for p
Increased plasma CRP and IL-6
Is there delayed restenosis in
Elevated circulating inflammat
The role of inflammation in co
Is inflammation a contributor
Xuezhikang decrease plasma inf
他汀类药物非调脂作用及其机制（续完）
内皮祖兰田胞、动脉硬化与炎症
炎症与支架内再狭窄
炎症可能是联接高血压和动脉粥样硬化的桥梁
Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response
Inflammatory response, drug-eluting stent and restenosis
C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway
Angiographic prevalence of myocardial bridging in a defined very large number of Chinese patients with chest pain
Effects of sirolimus-eluting stent on calcified coronary lesions